Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response

Treatment of chronic hepatitis C virus (HCV) infection is evolving rapidly with the development of novel direct acting antivirals (DAAs), however viral clearance remains intimately linked to the hepatic innate immune system. Patients demonstrating a high baseline activation of interferon stimulated...

Descripción completa

Detalles Bibliográficos
Autores principales: Read, Scott A., Tay, Enoch S., Shahidi, Mahsa, O’Connor, Kate S., Booth, David R., George, Jacob, Douglas, Mark W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551482/
https://www.ncbi.nlm.nih.gov/pubmed/26313459
http://dx.doi.org/10.1371/journal.pone.0136227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551482/
https://www.ncbi.nlm.nih.gov/pubmed/26313459
http://dx.doi.org/10.1371/journal.pone.0136227

Ejemplares similares